CREAL Closes USD 8.9M investment round to advance vision care and AR
11.07.2025
Swiss startup CREAL has raised USD 8.9 million in an equity funding round led by ZEISS, with participation from both new and existing investors, including members of the UBS private investor network. The funding will support the company's continued push to commercialize its proprietary light field display technology in the vision care and augmented reality (AR) sectors.
 |
 |
"The TOP 100 in our home Lausanne last year created one of the extremely rare situations: our pitch, investor (from UBS) likes it and approaches us, and then we close the investment, straightforward. We already knew each other, but timing was perfect and the event was catalytic."
Tomas Sluka, Co-Founder and CEO of CREAL.
The newly secured capital will accelerate the launch of a digitized vision care platform powered by CREAL's light field display, developed under a licensing agreement with ZEISS. In parallel, CREAL will continue to refine and miniaturize its AR light field module, advancing toward integration into lightweight, everyday AR glasses.
This latest round brings CREAL's total funding to over USD 32 million. In addition to ZEISS, past investors include Swisscom Ventures, Verve Ventures, and DAA Capital Partners.
CREAL's light field technology aims to deliver more natural and comfortable digital visual experiences by replicating how the human eye perceives depth and focus. With the support of ZEISS and other strategic investors, the company is preparing its technology for broader adoption in both consumer and medical applications.
The engineering company won Venture Kick, took part in Venture Leaders Technology and Mobile, and was ranked among the TOP 100 Swiss Startups.
